Freshpet, Inc. filings document formal disclosures for its refrigerated fresh pet food business, with recurring 8-K reports on quarterly and annual results, Regulation FD presentations, and reconciliations of non-GAAP measures such as adjusted gross profit, adjusted EBITDA, and free cash flow. The filings connect operating results to net sales, gross margin, input costs, plant expenses, and outlook commentary.
Proxy and compensation-related filings cover annual meeting matters, board governance, executive compensation, equity incentive awards, restricted stock units, inducement grants, and officer transitions. These documents also describe the company’s common stock, shareholder voting procedures, governance committees, and management accountability for Freshpet’s growth strategy and refrigerated distribution model.
O'Connor John Gregory reported acquisition or exercise transactions in this Form 4 filing.
Freshpet, Inc. reported that Chief Financial Officer John Gregory O'Connor received a grant of 4,814 shares of Common Stock in the form of restricted stock units under the Freshpet, Inc. 2024 Equity Incentive Plan. These units vest in three equal annual installments beginning on March 15, 2027, subject to his continued service. Following this award, he holds 12,314 shares of Common Stock directly.
Kelley Jacki Sue reported acquisition or exercise transactions in this Form 4 filing.
Freshpet, Inc. director Jacki Sue Kelley reported receiving a grant of 1,589 shares of restricted Common Stock as equity compensation. The award was made at no cost and increased her direct holdings to 13,496 shares. These restricted shares vest on March 15, 2027, provided she continues to serve on Freshpet’s Board of Directors through that date.
WEST DAVID J reported acquisition or exercise transactions in this Form 4 filing.
Freshpet director David J. West received an equity award of 1,589 shares of restricted common stock. The grant was made under Freshpet’s 2024 Equity Incentive Plan at no cash cost to him and brings his direct holdings to 5,953 shares of common stock.
The restricted shares are scheduled to vest on March 15, 2027, provided West continues to serve on Freshpet’s Board of Directors through that date. This filing reflects routine director compensation in the form of long-term, stock-based incentives.
BREWSTER DARYL G reported acquisition or exercise transactions in this Form 4 filing.
Freshpet, Inc. director Daryl G. Brewster received an award of 1,589 shares of restricted common stock as equity compensation. The stock was granted at no cash cost and was issued under the company’s 2024 Equity Incentive Plan.
These restricted shares are scheduled to vest on March 15, 2027, provided Brewster continues serving on Freshpet’s Board of Directors through that date. After this grant, he directly holds a total of 59,334 shares of Freshpet common stock.
Biegger David reported acquisition or exercise transactions in this Form 4 filing.
Freshpet, Inc. director David Biegger received an award of 1,589 shares of restricted common stock, with no cash paid per share. The grant was made under the company’s 2024 Equity Incentive Plan and will vest on March 15, 2027, if he continues serving on the board. Following this award, he directly holds 7,488 common shares.
Walsh Cathal reported acquisition or exercise transactions in this Form 4 filing.
Freshpet, Inc. senior vice president and Managing Director, Europe, Cathal Walsh reported an equity award on Common Stock. He received 1,299 restricted stock units under the Freshpet, Inc. 2024 Equity Incentive Plan, increasing his direct holdings to 7,701 shares after the transaction.
The restricted stock units are scheduled to vest in three equal annual installments beginning on March 15, 2027. Vesting is contingent on Walsh’s continued service with the company, aligning his compensation with longer‑term performance and retention.
Steeneck Craig D. reported acquisition or exercise transactions in this Form 4 filing.
Freshpet, Inc. director Craig D. Steeneck received an award of 1,589 shares of restricted Common Stock as equity compensation. These shares were granted at no cash cost and increase his direct holdings to 35,500 shares. The restricted shares were issued under Freshpet's 2024 Equity Incentive Plan and are scheduled to vest on March 15, 2027, provided he continues serving on the Board of Directors through that date.
Baty Nicola J. reported acquisition or exercise transactions in this Form 4 filing.
Freshpet, Inc. reported that Chief Operating Officer Nicola J. Baty received an award of 5,382 shares of Common Stock in the form of restricted stock units under the Freshpet, Inc. 2024 Equity Incentive Plan. These units carry no purchase price and increase her direct holdings to 38,716 shares.
The restricted stock units are scheduled to vest in three equal annual installments beginning on March 15, 2027, and each installment is conditioned on her continued service with the company. This filing reflects a compensation-related equity grant rather than an open-market share purchase or sale.
Freshpet, Inc. director Walter N. George purchased 630 shares of common stock in an open-market transaction at a weighted average price of $79.04 per share on February 25, 2026. Following this purchase, he directly owns 47,157 Freshpet shares.
Freshpet, Inc. makes fresh, refrigerated dog and cat food and treats, targeting the over $56.0 billion U.S. pet food market. The company focuses on health‑ and wellness‑oriented “pet parents,” selling mainly through branded Freshpet Fridges in blue‑chip retailers.
As of December 31, 2025, Freshpet products were in approximately 30,235 stores, with about 24% having multiple fridges, and household penetration around 15.2 million U.S. households. Walmart and Costco represented roughly 25% and 10% of net sales, respectively, and the company employed 1,288 people.
Freshpet highlights growth opportunities from expanding manufacturing capacity in Pennsylvania and Texas, product innovation and international expansion, while warning of risks including intense competition, dependence on key customers and distributors, commodity cost volatility, supply chain disruptions, product recalls, regulatory changes, technology and cyber risks, AI implementation risks, and potential limits on using federal NOL carryforwards of about $391.1 million and state NOLs of about $275.4 million.